4//SEC Filing
ANKCORN MICHAEL F 4
Accession 0000950103-04-001475
CIK 0001100682other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 4:21 PM ET
Size
9.8 KB
Accession
0000950103-04-001475
Insider Transaction Report
Form 4
ANKCORN MICHAEL F
Corporate Sr. Vice President
Transactions
- Award
Common Stock
2004-10-20+65,515→ 65,515 total - Award
Employee Stock Option (right to buy)
2004-10-20+23,670→ 23,670 totalExercise: $29.97Exp: 2014-01-30→ Common Stock (23,670 underlying) - Award
Employee Stock Option (right to buy)
2004-10-20+7,890→ 7,890 totalExercise: $22.50Exp: 2013-06-28→ Common Stock (7,890 underlying)
Footnotes (4)
- [F1]Shares and options to purchase shares of Issuer common stock were acquired pursuant to the transactions contemplated by the Agreement and Plan of Merger dated as of June 30, 2004, by and among the Issuer, Inveresk Research Group, Inc. Indigo Merger I Corp. and Indigo Merger II LLC (successor to Indigo Merger II Corp.).
- [F2]Received in exchange for 136,490 shares of Inveresk common stock in connection with the Merger.
- [F3]3,945 options are exercisable on each of 6/28/05 and 6/28/06.
- [F4]7,890 options are exercisable on each of 1/30/05, 1/30/06 and 1/30/07.
Documents
Issuer
CHARLES RIVER LABORATORIES INTERNATIONAL INC
CIK 0001100682
Entity typeother
Related Parties
1- filerCIK 0001226479
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 4:21 PM ET
- Size
- 9.8 KB